Gracell Biotech of Suzhou completed a $209 million NASDAQ IPO for its next-gen CAR-T treatments. APT Medical completed a $191 million IPO on the Shanghai STAR Exchange, rising 245% in its first trading session to a market cap of $2.7 billion.